AMLODIPINE/VALSARTAN TEVA 5/80 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

amlodipine/valsartan teva 5/80 milligram film coated tablet

teva b.v. - valsartan, amlodipine besilate - film coated tablet - 5/80 milligram - angiotensin ii antagonists and calcium channel blockers

AMLODIPINE/VALSARTAN TEVA 5/160 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

amlodipine/valsartan teva 5/160 milligram film coated tablet

teva b.v. - valsartan, amlodipine besilate - film coated tablet - 5/160 milligram - angiotensin ii antagonists and calcium channel blockers

AMLODIPINE/VALSARTAN TEVA 10/160 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

amlodipine/valsartan teva 10/160 milligram film coated tablet

teva b.v. - valsartan, amlodipine besilate - film coated tablet - 10/160 milligram - angiotensin ii antagonists and calcium channel blockers

AMLODIPINE/VALSARTAN NOVARTIS 10/160 amlodipine 10 mg/valsartan 160 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine/valsartan novartis 10/160 amlodipine 10 mg/valsartan 160 mg film-coated tablet blister pack

novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; crospovidone; titanium dioxide; hypromellose; purified talc; macrogol 4000; iron oxide red; iron oxide yellow - amlodipine/valsartan novartis is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Amlodipine/Valsartan/Hydrochlorothiazide Rowex 10 mg/160 mg/12.5 mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

amlodipine/valsartan/hydrochlorothiazide rowex 10 mg/160 mg/12.5 mg film-coated tablets

rowex ltd - amlodipine besilate; valsartan; hydrochlorothiazide - film-coated tablet - 10/160/12.5 milligram(s) - angiotensin ii antagonists, other combinations; valsartan, amlodipine and hydrochlorothiazide

Amlodipine/Valsartan/Hydrochlorothiazide Rowex 10 mg/160 mg/25 mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

amlodipine/valsartan/hydrochlorothiazide rowex 10 mg/160 mg/25 mg film-coated tablets

rowex ltd - amlodipine besilate; valsartan; hydrochlorothiazide - film-coated tablet - 10/160/25 milligram(s) - angiotensin ii antagonists, other combinations; valsartan, amlodipine and hydrochlorothiazide

Amlodipine/Valsartan/Hydrochlorothiazide Rowex 10 mg/320 mg/25 mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

amlodipine/valsartan/hydrochlorothiazide rowex 10 mg/320 mg/25 mg film-coated tablets

rowex ltd - amlodipine besilate; valsartan; hydrochlorothiazide - film-coated tablet - 10/320/25 milligram(s) - angiotensin ii antagonists, other combinations; valsartan, amlodipine and hydrochlorothiazide

Amlodipine/Valsartan/Hydrochlorothiazide Rowex 5 mg/160 mg/12.5 mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

amlodipine/valsartan/hydrochlorothiazide rowex 5 mg/160 mg/12.5 mg film-coated tablets

rowex ltd - amlodipine besilate; valsartan; hydrochlorothiazide - film-coated tablet - 5/160/12.5 milligram(s) - angiotensin ii antagonists, other combinations; valsartan, amlodipine and hydrochlorothiazide

Amlodipine/Valsartan/Hydrochlorothiazide Rowex 5 mg/160 mg/25 mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

amlodipine/valsartan/hydrochlorothiazide rowex 5 mg/160 mg/25 mg film-coated tablets

rowex ltd - amlodipine besilate; valsartan; hydrochlorothiazide - film-coated tablet - 5/160/25 milligram(s) - angiotensin ii antagonists, other combinations; valsartan, amlodipine and hydrochlorothiazide

EXFORGE HCT 10/320/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

exforge hct 10/320/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack

novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 25 mg; valsartan, quantity: 320 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; crospovidone; hypromellose; purified talc; iron oxide yellow; macrogol 4000 - exforge hct is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).